Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Dec 15;102(12):2106–2114. doi: 10.1172/JCI3459

Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts.

E Gazzerro 1, V Gangji 1, E Canalis 1
PMCID: PMC509165  PMID: 9854046

Abstract

Bone morphogenetic proteins (BMPs) induce the differentiation of cells of the osteoblastic lineage and enhance the function of the osteoblast. Growth factors are regulated by binding proteins, but there is no information about binding proteins for BMPs in skeletal cells. Noggin specifically binds BMPs, but its expression by cells of the osteoblastic lineage has not been reported. We tested for the expression of noggin and its induction by BMP-2 in cultures of osteoblast-enriched cells from 22-d-old fetal rat calvariae (Ob cells). BMP-2 caused a time- and dose-dependent increase in noggin mRNA and polypeptide levels, as determined by Northern and Western blot analyses. The effects of BMP-2 on noggin transcripts were dependent on protein, but independent of DNA synthesis. BMP-2 increased the rates of noggin transcription as determined by nuclear run-on assays. BMP-4, BMP-6, and TGF-beta1 increased noggin mRNA in Ob cells, but basic fibroblast growth factor, platelet- derived growth factor BB, and IGF-I did not. Noggin decreased the stimulatory effects of BMPs on DNA and collagen synthesis and alkaline phosphatase activity in Ob cells. In conclusion, BMPs induce noggin transcription in Ob cells, a probable mechanism to limit BMP action in osteoblasts.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andress D. L., Birnbaum R. S. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem. 1992 Nov 5;267(31):22467–22472. [PubMed] [Google Scholar]
  2. Boden S. D., Hair G., Titus L., Racine M., McCuaig K., Wozney J. M., Nanes M. S. Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. Endocrinology. 1997 Jul;138(7):2820–2828. doi: 10.1210/endo.138.7.5125. [DOI] [PubMed] [Google Scholar]
  3. Brunet L. J., McMahon J. A., McMahon A. P., Harland R. M. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science. 1998 May 29;280(5368):1455–1457. doi: 10.1126/science.280.5368.1455. [DOI] [PubMed] [Google Scholar]
  4. Canalis E., Centrella M., Urist M. R. Effect of partially purified bone morphogenetic protein on DNA synthesis and cell replication in calvarial and fibroblast cultures. Clin Orthop Relat Res. 1985 Sep;(198):289–296. [PubMed] [Google Scholar]
  5. Canalis E., Pash J., Varghese S. Skeletal growth factors. Crit Rev Eukaryot Gene Expr. 1993;3(3):155–166. [PubMed] [Google Scholar]
  6. Celeste A. J., Iannazzi J. A., Taylor R. C., Hewick R. M., Rosen V., Wang E. A., Wozney J. M. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9843–9847. doi: 10.1073/pnas.87.24.9843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Centrella M., McCarthy T. L., Canalis E. Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol Cell Biol. 1991 Sep;11(9):4490–4496. doi: 10.1128/mcb.11.9.4490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Centrella M., McCarthy T. L., Canalis E. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem. 1987 Feb 25;262(6):2869–2874. [PubMed] [Google Scholar]
  9. Centrella M., McCarthy T. L., Kusmik W. F., Canalis E. Relative binding and biochemical effects of heterodimeric and homodimeric isoforms of platelet-derived growth factor in osteoblast-enriched cultures from fetal rat bone. J Cell Physiol. 1991 Jun;147(3):420–426. doi: 10.1002/jcp.1041470306. [DOI] [PubMed] [Google Scholar]
  10. Chen T. L., Bates R. L., Dudley A., Hammonds R. G., Jr, Amento E. P. Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells: comparison with TGF-beta 1. J Bone Miner Res. 1991 Dec;6(12):1387–1393. doi: 10.1002/jbmr.5650061216. [DOI] [PubMed] [Google Scholar]
  11. Delany A. M., Jeffrey J. J., Rydziel S., Canalis E. Cortisol increases interstitial collagenase expression in osteoblasts by post-transcriptional mechanisms. J Biol Chem. 1995 Nov 3;270(44):26607–26612. doi: 10.1074/jbc.270.44.26607. [DOI] [PubMed] [Google Scholar]
  12. Dong Y., Canalis E. Insulin-like growth factor (IGF) I and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells. Endocrinology. 1995 May;136(5):2000–2006. doi: 10.1210/endo.136.5.7536661. [DOI] [PubMed] [Google Scholar]
  13. Feinberg A. P., Vogelstein B. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem. 1984 Feb;137(1):266–267. doi: 10.1016/0003-2697(84)90381-6. [DOI] [PubMed] [Google Scholar]
  14. Funaba M., Ogawa K., Murata T., Fujimura H., Murata E., Abe M., Takahashi M., Torii K. Follistatin and activin in bone: expression and localization during endochondral bone development. Endocrinology. 1996 Oct;137(10):4250–4259. doi: 10.1210/endo.137.10.8828484. [DOI] [PubMed] [Google Scholar]
  15. Ghosh-Choudhury N., Harris M. A., Feng J. Q., Mundy G. R., Harris S. E. Expression of the BMP 2 gene during bone cell differentiation. Crit Rev Eukaryot Gene Expr. 1994;4(2-3):345–355. doi: 10.1615/critreveukargeneexpr.v4.i2-3.30. [DOI] [PubMed] [Google Scholar]
  16. Hashimoto M., Shoda A., Inoue S., Yamada R., Kondo T., Sakurai T., Ueno N., Muramatsu M. Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin. J Biol Chem. 1992 Mar 5;267(7):4999–5004. [PubMed] [Google Scholar]
  17. Hock J. M., Centrella M., Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology. 1988 Jan;122(1):254–260. doi: 10.1210/endo-122-1-254. [DOI] [PubMed] [Google Scholar]
  18. Holley S. A., Neul J. L., Attisano L., Wrana J. L., Sasai Y., O'Connor M. B., De Robertis E. M., Ferguson E. L. The Xenopus dorsalizing factor noggin ventralizes Drosophila embryos by preventing DPP from activating its receptor. Cell. 1996 Aug 23;86(4):607–617. doi: 10.1016/s0092-8674(00)80134-8. [DOI] [PubMed] [Google Scholar]
  19. Hughes F. J., Collyer J., Stanfield M., Goodman S. A. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology. 1995 Jun;136(6):2671–2677. doi: 10.1210/endo.136.6.7750491. [DOI] [PubMed] [Google Scholar]
  20. Iwasaki S., Tsuruoka N., Hattori A., Sato M., Tsujimoto M., Kohno M. Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2. J Biol Chem. 1995 Mar 10;270(10):5476–5482. doi: 10.1074/jbc.270.10.5476. [DOI] [PubMed] [Google Scholar]
  21. Jones C. M., Simon-Chazottes D., Guenet J. L., Hogan B. L. Isolation of Vgr-2, a novel member of the transforming growth factor-beta-related gene family. Mol Endocrinol. 1992 Nov;6(11):1961–1968. doi: 10.1210/mend.6.11.1480182. [DOI] [PubMed] [Google Scholar]
  22. Jones J. I., Gockerman A., Busby W. H., Jr, Camacho-Hubner C., Clemmons D. R. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol. 1993 May;121(3):679–687. doi: 10.1083/jcb.121.3.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Knudsen B. S., Harpel P. C., Nachman R. L. Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. J Clin Invest. 1987 Oct;80(4):1082–1089. doi: 10.1172/JCI113164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  25. Letsou A., Arora K., Wrana J. L., Simin K., Twombly V., Jamal J., Staehling-Hampton K., Hoffmann F. M., Gelbart W. M., Massagué J. Drosophila Dpp signaling is mediated by the punt gene product: a dual ligand-binding type II receptor of the TGF beta receptor family. Cell. 1995 Mar 24;80(6):899–908. doi: 10.1016/0092-8674(95)90293-7. [DOI] [PubMed] [Google Scholar]
  26. Luyten F. P., Cunningham N. S., Ma S., Muthukumaran N., Hammonds R. G., Nevins W. B., Woods W. I., Reddi A. H. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem. 1989 Aug 15;264(23):13377–13380. [PubMed] [Google Scholar]
  27. Luyten F. P., Yu Y. M., Yanagishita M., Vukicevic S., Hammonds R. G., Reddi A. H. Natural bovine osteogenin and recombinant human bone morphogenetic protein-2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant cultures. J Biol Chem. 1992 Feb 25;267(6):3691–3695. [PubMed] [Google Scholar]
  28. McCarthy T. L., Casinghino S., Centrella M., Canalis E. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors. J Cell Physiol. 1994 Jul;160(1):163–175. doi: 10.1002/jcp.1041600119. [DOI] [PubMed] [Google Scholar]
  29. McCarthy T. L., Centrella M., Canalis E. Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures. J Biol Chem. 1990 Sep 15;265(26):15353–15356. [PubMed] [Google Scholar]
  30. McCarthy T. L., Centrella M., Canalis E. Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. Endocrinology. 1989 Oct;125(4):2118–2126. doi: 10.1210/endo-125-4-2118. [DOI] [PubMed] [Google Scholar]
  31. McCarthy T. L., Centrella M., Canalis E. Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J Bone Miner Res. 1988 Aug;3(4):401–408. doi: 10.1002/jbmr.5650030406. [DOI] [PubMed] [Google Scholar]
  32. Nakamura T., Takio K., Eto Y., Shibai H., Titani K., Sugino H. Activin-binding protein from rat ovary is follistatin. Science. 1990 Feb 16;247(4944):836–838. doi: 10.1126/science.2106159. [DOI] [PubMed] [Google Scholar]
  33. Ozkaynak E., Rueger D. C., Drier E. A., Corbett C., Ridge R. J., Sampath T. K., Oppermann H. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J. 1990 Jul;9(7):2085–2093. doi: 10.1002/j.1460-2075.1990.tb07376.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ozkaynak E., Schnegelsberg P. N., Jin D. F., Clifford G. M., Warren F. D., Drier E. A., Oppermann H. Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. J Biol Chem. 1992 Dec 15;267(35):25220–25227. [PubMed] [Google Scholar]
  35. Penton A., Chen Y., Staehling-Hampton K., Wrana J. L., Attisano L., Szidonya J., Cassill J. A., Massagué J., Hoffmann F. M. Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell. 1994 Jul 29;78(2):239–250. doi: 10.1016/0092-8674(94)90294-1. [DOI] [PubMed] [Google Scholar]
  36. Peterkofsky B., Diegelmann R. Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry. 1971 Mar 16;10(6):988–994. doi: 10.1021/bi00782a009. [DOI] [PubMed] [Google Scholar]
  37. Piccolo S., Sasai Y., Lu B., De Robertis E. M. Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell. 1996 Aug 23;86(4):589–598. doi: 10.1016/s0092-8674(00)80132-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rechler M. M. Insulin-like growth factor binding proteins. Vitam Horm. 1993;47:1–114. doi: 10.1016/s0083-6729(08)60444-6. [DOI] [PubMed] [Google Scholar]
  39. Rosenzweig B. L., Imamura T., Okadome T., Cox G. N., Yamashita H., ten Dijke P., Heldin C. H., Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7632–7636. doi: 10.1073/pnas.92.17.7632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sasai Y., Lu B., Steinbeisser H., Geissert D., Gont L. K., De Robertis E. M. Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell. 1994 Dec 2;79(5):779–790. doi: 10.1016/0092-8674(94)90068-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shafritz A. B., Shore E. M., Gannon F. H., Zasloff M. A., Taub R., Muenke M., Kaplan F. S. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med. 1996 Aug 22;335(8):555–561. doi: 10.1056/NEJM199608223350804. [DOI] [PubMed] [Google Scholar]
  42. Smith W. C., Harland R. M. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell. 1992 Sep 4;70(5):829–840. doi: 10.1016/0092-8674(92)90316-5. [DOI] [PubMed] [Google Scholar]
  43. Sudo H., Kodama H. A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol. 1983 Jan;96(1):191–198. doi: 10.1083/jcb.96.1.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Takuwa Y., Ohse C., Wang E. A., Wozney J. M., Yamashita K. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun. 1991 Jan 15;174(1):96–101. doi: 10.1016/0006-291x(91)90490-x. [DOI] [PubMed] [Google Scholar]
  45. Thies R. S., Bauduy M., Ashton B. A., Kurtzberg L., Wozney J. M., Rosen V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology. 1992 Mar;130(3):1318–1324. doi: 10.1210/endo.130.3.1311236. [DOI] [PubMed] [Google Scholar]
  46. Valenzuela D. M., Economides A. N., Rojas E., Lamb T. M., Nuñez L., Jones P., Lp N. Y., Espinosa R., 3rd, Brannan C. I., Gilbert D. J. Identification of mammalian noggin and its expression in the adult nervous system. J Neurosci. 1995 Sep;15(9):6077–6084. doi: 10.1523/JNEUROSCI.15-09-06077.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Varghese S., Canalis E. Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures. Endocrinology. 1997 Mar;138(3):1035–1040. doi: 10.1210/endo.138.3.4978. [DOI] [PubMed] [Google Scholar]
  48. Wang E. A., Rosen V., D'Alessandro J. S., Bauduy M., Cordes P., Harada T., Israel D. I., Hewick R. M., Kerns K. M., LaPan P. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2220–2224. doi: 10.1073/pnas.87.6.2220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Wozney J. M., Rosen V., Celeste A. J., Mitsock L. M., Whitters M. J., Kriz R. W., Hewick R. M., Wang E. A. Novel regulators of bone formation: molecular clones and activities. Science. 1988 Dec 16;242(4885):1528–1534. doi: 10.1126/science.3201241. [DOI] [PubMed] [Google Scholar]
  50. Yamaguchi A., Katagiri T., Ikeda T., Wozney J. M., Rosen V., Wang E. A., Kahn A. J., Suda T., Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol. 1991 May;113(3):681–687. doi: 10.1083/jcb.113.3.681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Zhang Y. Q., Kanzaki M., Shibata H., Kojima I. Regulation of the expression of follistatin in rat hepatocytes. Biochim Biophys Acta. 1997 Nov 20;1354(3):204–210. doi: 10.1016/s0167-4781(97)00085-7. [DOI] [PubMed] [Google Scholar]
  52. Zimmerman L. B., De Jesús-Escobar J. M., Harland R. M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 1996 Aug 23;86(4):599–606. doi: 10.1016/s0092-8674(00)80133-6. [DOI] [PubMed] [Google Scholar]
  53. ten Dijke P., Yamashita H., Sampath T. K., Reddi A. H., Estevez M., Riddle D. L., Ichijo H., Heldin C. H., Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem. 1994 Jun 24;269(25):16985–16988. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES